ORIGINAL RESEARCH: Abstracts must summarize hypothesis-driven research findings. Basic, clinical, translational, dissemination/implementation, or educational research are examples of acceptable research. Topics should appeal to a clinical pharmacy audience and may include: research in drug metabolism, education/pedagogy, health services, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or animal research are welcome.
- Abstracts will be evaluated based on merits of hypotheses/objectives, study design, results, and conclusions.
- Descriptions of planned research efforts or preliminary data will not be accepted.
- To be eligible for the Best Paper Award, or Student, Resident, or Fellow Best Paper Award the abstract must be submitted under this category.
- A previously presented abstract may form the basis for a new abstract to be submitted for consideration in the Original
Research category if the previous abstract:
- was a descriptive report of planned research only,
- described preliminary results only and complete results are now available,
- was presented at a student, resident, or fellow conference focused on gaining presentation experience and/or formative feedback,
- was presented at an ACCP Chapter or PRN event, or
- conclusions have been added/modified based on a new hypothesis and data analysis of the original results database.
** A copy of the original abstract and the full citation of where/when the research was presented must accompany submission. ACCP reserves the right to determine the extent of difference necessary to substantiate a new Original Research abstract submission.
CLINICAL PHARMACY FORUM: Abstracts must describe the development, delivery, justification, or documentation of innovative clinical pharmacy services. Abstracts that address components of the ACCP Standards of Practice for Clinical Pharmacists (see
http://www.accp.com/docs/positions/guidelines/standardsofpractice.pdf) and/or describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged.
Abstracts may be descriptive and need not contain an evaluative component.
- Abstracts will be evaluated based on originality of the service or program, adequacy of justification/documentation, adaptability to other settings, and significance to clinical pharmacy.
- The abstract must not have been published in abstract form or presented elsewhere.
STUDENT, RESIDENT, or FELLOW RESEARCH-IN-PROGRESS:
Submission and evaluation criteria are those of an Original Research abstract except that the research effort is ongoing. Descriptions of planned research efforts without data should not be submitted. Submission of partially completed data is acceptable. Abstracts should provide an assessment of likelihood of project completion by date of presentation.
- A presenting student author must be a first professional degree (Pharm.D. or BS Pharm) student and a presenting resident or fellow author must be in a post-graduate training program (PGY-1 or PGY-2 residency, Ph.D./Masters graduate degree program, or fellowship program).
- Abstracts submitted in the Student, Resident, or Fellow Research in Progress category are not eligible for the Student, Resident or Fellow Best Paper competition. *Note: to be eligible for the Student, Resident, or Fellow Best Paper competition(s), the research must be complete and the abstract submitted under the Original Research category, indicating that it was conducted by a student, resident, or fellow.
Submission Deadline
The deadline to submit abstracts in the Original Research, Clinical Pharmacy Forum, and Student, Resident, or Fellow Research-in-Progress categories is Sunday, January 18, 2015, 11:59 p.m. (PST).
Acceptance Notification
Authors will be notified by e-mail of acceptance of their papers by Tuesday, March 31, 2015.
Best Paper finalists will be notified by May 11, 2015 and will be judged during the Virtual Poster Symposium by a panel of judges.
Virtual Poster Symposium Information — Please read it prior to submitting your abstract.